Chakshu Research

12.16.08

Chakshu Initiates New Trial for Treating Cataract…
Learn More >

Carol F. H. Harner, Vice President, Research & Development

"Directing such exciting research is both provoking and professionally satisfying

Management Team

Inspiring Scientific Endeavors

Carol Harner gets excited about great scientists conducting great research. The opportunity to direct a cadre of researchers who are focused on developing a potentially ubiquitous drug addressing the disease pathology of oxidative stress lured her attention to Chakshu.

She brings her salient experience with other entrepreneurial and small companies to Chakshu, knowing what it takes to get to the market with a safe and effective drug. In fact, the chance to have such a critical impact on Chakshu’s drug development provokes her enthusiasm.

Lifework

Dr. Harner most recently served as Sr. VP, Emerging Technologies and Alliances and as Sr. VP, Research & Development for AMO in Santa Clara, CA where she directed research activities related to VISX refractive surgery products, identified emerging technologies and structured research/development alliances for AMO. Prior to that, she served as Sr. VP, Research and Development for VISX where she directed research activities for VISX’s refractive surgery products; laser systems, Wavefront analysis systems and tracking systems. She also directed research activities relating to the investigation of new technologies and the design and development of Collagen Corporation’s products for orthopaedics, plastic surgery, dermatology and gastroenterology.

Dr. Harner is a published author with extensive academic experience as a Professor of Biological Sciences at the University of Utah and the University of Denver.

Formal Education

Carol received both her B.S. and Ph.D. in Molecular Biology at the University of Utah.